Drew Messick

Chief Financial Officer

Finance professional with over 20 years of experience driving growth through the successful implementation of financial and operational strategies. Most recently served as the Chief Financial Officer of two privately held life science and technology companies. Drew holds a master’s degree in accounting and is a Chartered Financial Analyst and CPA.

Back to our Team

Mission Statement

The mission of Castle IRB is to protect the rights and welfare of human participants in gene and cell therapy clinical trials while providing efficient, compliant IRB review of research. Using our portfolio of expertise, we strive to be the leading IRB partner in advancing safe, ethical and compliant gene and cell therapy clinical trials to accelerate the next evolution in advanced therapies.